20 May 2013
Keywords: zila, deal, signed, european, australian, licensing, distribution
Article | 17 April 1995
- Zila has signed a European and Australian licensing and
distribution agreement with Block Drug for its OraScan cancer diagnostic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com